Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
2,139,852
-
Total 13F shares
-
1,687,829
-
Share change
-
-147,820
-
Total reported value
-
$6,751,000
-
Price per share
-
$4.00
-
Number of holders
-
9
-
Value change
-
-$661,029
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) as of Q1 2022
As of 31 Mar 2022,
Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,687,829 shares.
The largest 9 holders included
Stratos Wealth Partners, LTD., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, INVESTMENT HOUSE LLC, STATE STREET CORP, UNITED CAPITAL FINANCIAL ADVISERS, LLC, NORTHERN TRUST CORP, UBS Group AG, and NATIONAL BANK OF CANADA /FI/.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.